Blood derivative in-vitro diagnostic substances manufacturing · New Jersey

Ortho Clinical Diagnostics Raritan

Raritan, NJ · ~972 workers · 4 years of OSHA Injury Tracking Application data.

B
Good Safety Record
1.8
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Ortho Clinical Diagnostics Raritan runs at 55% of its industry's injury rate - safer than the typical Blood derivative in-vitro diagnostic substances manufacturing workplace, earning a grade B.

Ortho Clinical Diagnostics Raritan: 1.8 TCR = 55% of Blood derivative in-vitro diagnostic substances manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

Ortho Clinical Diagnostics Raritan safety composite

Ortho Clinical Diagnostics Raritan scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on dart rate (safer than 31%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

37/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
D 1.81 per 100 workers

Safer than 35% of industry peers

DART rate
F 1.46 per 100 workers

Safer than 31% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Ortho Clinical Diagnostics Raritan: 0.7 → 2.1 TCR

Peak year 2021 @ 2.3 TCR · DART/TCR 0.81× in 2022

Ortho Clinical Diagnostics Raritan's TCR rose 1.5 from 0.7 in 2019 to 2.1 in 2022. Peak filing year was 2021 at 2.3 TCR. In 2022, DART was 0.81× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325413 · Raritan, NJ AT/BELOW-IND · MID

Grade B · TCR 1.8 · 55% of ind

  • DART 1.5 DART
  • RANK #7/11
  • PHOTO Cedar Creek
  • BOOK 4y book
  • INJ 48 inj
  • SIZE ~972 FTE

Nearest TCR peer: Cedar Creek (0.0 TCR gap)

Read with this employer → · Industry book → · New Jersey employers → · Look up another →

Ortho Clinical Diagnostics Raritan in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Ortho Clinical Diagnostics Raritan averages 1.8 TCR (55% of the Blood derivative in-vitro diagnostic substances manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Ortho Clinical Diagnostics Raritan TCR series: 2019=0.7 · 2020=2.1 · 2021=2.3 · 2022=2.1 · BLS 3.3

Where Ortho Clinical Diagnostics Raritan falls in its industry

201 Blood derivative in-vitro diag establishments

Safer than 35% of graded establishments in this industry, whose median TCR is 1.4.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #7 safest of 11 Blood derivative in-vitro diag employers in New Jersey.

Ortho Clinical Diagnostics Raritan (972 employees, TCR 1.8) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 02,0004,0006,000 01234 Average employees Total Case Rate Ortho Clinical Diagnostics Raritan
Ortho Clinical Diagnostics Raritan (972 employees, TCR 1.8) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4

Ortho Clinical Diagnostics Raritan has more employees than the Blood derivative in-vitro diagnostic sub median and a higher injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2022 2.1 1.5 18 7 0
2021 2.3 1.8 10 16 0
2020 2.1 1.4 13 9 0
2019 0.7 0.5 7 1 0

OSHA ITA peer cross-reference

Establishment peer ledger

325413 · NJ · Raritan

201 Blood derivative in-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 11,201 rated employers in New Jersey with headcount on file · 15 employers in Raritan, NJ · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Cedar Creek 1.8 TCR
NAICS-TCR TriLink Biotechnologies LLC 1.8 TCR
NAICS-TCR ID Westbrook 1.8 TCR
NAICS-TCR Thermo Fisher Scientific MBD-US 1.8 TCR
STATE-SIZE US Specialty Brands Headquarters 969 FTE
STATE-SIZE Colgate-Palmolive Company 978 FTE
STATE-SIZE Colgate-Palmolive Global Technology Center 978 FTE
STATE-SIZE 86080B01 CVS PHARMACY, INC. 963 FTE
CITY-NEAR Janssen Pharmaceuticals Raritan 3,286 FTE
CITY-NEAR Ortho Clinical Diagnostics- Raritan 1,261 FTE
CITY-NEAR Information Technology Services Raritan 866 FTE
CITY-NEAR QuidelOrtho Raritan 521 FTE
NAT-TCR Premier Technology, Inc. 1.8 TCR
NAT-TCR 652 - North Glendale 1.8 TCR
NAT-TCR 1473 - Greer 1.8 TCR
NAT-TCR Jackson Therapy Partners, LLC. 1.8 TCR
NAT-SIZE Discovery Cove (DCO) 972 FTE
NAT-SIZE Delta Air Lines - DFW 972 FTE
NAT-SIZE Amazon.com Services LLC - SBD3 972 FTE
NAT-SIZE Hazleton Distribution Center 972 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2022, 2021, 2020, 2019. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.